Coya Therapeutics (COYA) Cash from Operations (QoQ) (2022 - 2026)
Coya Therapeutics (COYA) Cash from Operations (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Coya Therapeutics | 98.05 Mn | 47.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -516.46% |
| Dec 31, 2025 | 10.92% |
| Sep 30, 2025 | 80.42% |
| Jun 30, 2025 | -104.13% |
| Mar 31, 2025 | -17.37% |
| Dec 31, 2024 | 55.88% |
| Sep 30, 2024 | -19.67% |
| Jun 30, 2024 | -312.67% |
| Mar 31, 2024 | 195.75% |
| Dec 31, 2023 | -1.13% |
| Sep 30, 2023 | 22.73% |
| Jun 30, 2023 | 25.77% |
| Mar 31, 2023 | -73.80% |
| Dec 31, 2022 | -39.68% |
| Sep 30, 2022 | -10.52% |
| Jun 30, 2022 | 27.44% |